Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1990 1
1993 1
1998 2
1999 2
2000 3
2001 3
2002 1
2003 4
2004 4
2005 8
2006 6
2007 10
2008 7
2009 17
2010 11
2011 13
2012 18
2013 23
2014 21
2015 23
2016 19
2017 26
2018 22
2019 26
2020 32
2021 31
2022 52
2023 56
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

405 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %
The following terms were not found in PubMed: 20HY, 5BAuthor
Page 1
Decompressive Craniectomy versus Craniotomy for Acute Subdural Hematoma.
Hutchinson PJ, Adams H, Mohan M, Devi BI, Uff C, Hasan S, Mee H, Wilson MH, Gupta DK, Bulters D, Zolnourian A, McMahon CJ, Stovell MG, Al-Tamimi YZ, Tewari MK, Tripathi M, Thomson S, Viaroli E, Belli A, King AT, Helmy AE, Timofeev IS, Pyne S, Shukla DP, Bhat DI, Maas AR, Servadei F, Manley GT, Barton G, Turner C, Menon DK, Gregson B, Kolias AG; British Neurosurgical Trainee Research Collaborative, NIHR Global Health Research Group on Acquired Brain and Spine Injury, and RESCUE-ASDH Trial Collaborators; RESCUE-ASDH Trial Collaborators. Hutchinson PJ, et al. N Engl J Med. 2023 Jun 15;388(24):2219-2229. doi: 10.1056/NEJMoa2214172. Epub 2023 Apr 23. N Engl J Med. 2023. PMID: 37092792 Clinical Trial.
Secondary outcomes included the GOSE rating at 6 months and quality of life as assessed by the EuroQol Group 5-Dimension 5-Level questionnaire (EQ-5D-5L). RESULTS: A total of 228 patients were assigned to the craniotomy group and 222 to the decompressive craniectomy group. …
Secondary outcomes included the GOSE rating at 6 months and quality of life as assessed by the EuroQol Group 5-Dimension 5-Level questionnai …
Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for Advanced Urothelial Carcinoma.
Grivas P, Kopyltsov E, Su PJ, Parnis FX, Park SH, Yamamoto Y, Fong PC, Tournigand C, Climent Duran MA, Bamias A, Caserta C, Chang J, Cislo P, di Pietro A, Wang J, Powles T. Grivas P, et al. Eur Urol. 2023 Apr;83(4):320-328. doi: 10.1016/j.eururo.2022.04.016. Epub 2022 May 30. Eur Urol. 2023. PMID: 35654659 Free article. Clinical Trial.
OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Bladder Symptom Index-18 (FBlSI-18) and EuroQol five-level EQ-5D (EQ-5D-5L) assessments were analyzed using descriptive statistics and mixed- …
OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy Bladder Symptom …
Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial.
Fizazi K, Herrmann K, Krause BJ, Rahbar K, Chi KN, Morris MJ, Sartor O, Tagawa ST, Kendi AT, Vogelzang N, Calais J, Nagarajah J, Wei XX, Koshkin VS, Beauregard JM, Chang B, Ghouse R, DeSilvio M, Messmann RA, de Bono J. Fizazi K, et al. Lancet Oncol. 2023 Jun;24(6):597-610. doi: 10.1016/S1470-2045(23)00158-4. Lancet Oncol. 2023. PMID: 37269841 Clinical Trial.
Here we report the key secondary endpoint of time to first symptomatic skeletal event, and other secondary endpoints of HRQOL assessed with the Functional Assessment of Cancer Therapy-Prostate (FACT-P) and EQ-5D-5L, and pain assessed with the Brief Pain Inventory-Short For …
Here we report the key secondary endpoint of time to first symptomatic skeletal event, and other secondary endpoints of HRQOL assessed with …
Valuation of the EQ-5D-5L in Taiwan.
Lin HW, Li CI, Lin FJ, Chang JY, Gau CS, Luo N, Pickard AS, Ramos Goñi JM, Tang CH, Hsu CN. Lin HW, et al. PLoS One. 2018 Dec 26;13(12):e0209344. doi: 10.1371/journal.pone.0209344. eCollection 2018. PLoS One. 2018. PMID: 30586400 Free PMC article.
OBJECTIVES: To date, a value set for the EQ-5D-5L based on the health state preferences of the general Taiwanese population has not been available. ...METHODS: An international standardized protocol for EQ-5D-5L valuation studies developed by the EuroQol group was a …
OBJECTIVES: To date, a value set for the EQ-5D-5L based on the health state preferences of the general Taiwanese population has not b …
5D superresolution imaging for a live cell nucleus.
Chu LA, Chang SW, Tang WC, Tseng YT, Chen P, Chen BC. Chu LA, et al. Curr Opin Genet Dev. 2021 Apr;67:77-83. doi: 10.1016/j.gde.2020.11.005. Epub 2020 Dec 28. Curr Opin Genet Dev. 2021. PMID: 33383256 Review.
Symptom Burden, Health Status, and Productivity in Patients with Uncontrolled and Controlled Severe Asthma in NOVELTY.
Ding B, Chen S, Srivastava D, Quinton A, Cook W, Papi A, Reddel HK; NOVELTY Scientific Community; NOVELTY study investigators. Ding B, et al. J Asthma Allergy. 2023 Jun 11;16:611-624. doi: 10.2147/JAA.S401445. eCollection 2023. J Asthma Allergy. 2023. PMID: 37334017 Free PMC article.
Assessment of health status included St George's Respiratory Questionnaire (SGRQ), EuroQoL 5 Dimensions 5 Levels Health Questionnaire (EQ-5D-5L) index value, and EQ-5D-5L Visual Analog Score (EQ-VAS). Assessment of productivity loss included absenteeism, presenteeis …
Assessment of health status included St George's Respiratory Questionnaire (SGRQ), EuroQoL 5 Dimensions 5 Levels Health Questionnaire (EQ- …
Health utilities in burn injury survivors: A systematic review.
Synodinou D, Savoie-White FH, Sangone A, Chang SL, Beaudoin Cloutier C, Bergeron F, Guertin JR. Synodinou D, et al. Burns. 2022 Feb;48(1):13-22. doi: 10.1016/j.burns.2021.09.003. Epub 2021 Sep 17. Burns. 2022. PMID: 34844813 Review.
RESULTS: We identified 15 studies that reported burn injury survivors' utility scores. Most studies used the EQ-5D instruments to assess patients' utility scores. Results varied substantially between studies, ranging from a low of 0.06 to a high of 0.972. ...
RESULTS: We identified 15 studies that reported burn injury survivors' utility scores. Most studies used the EQ-5D instruments to ass …
Efficacy and safety of duloxetine in painful diabetic peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials.
Wu CS, Huang YJ, Ko YC, Lee CH. Wu CS, et al. Syst Rev. 2023 Mar 21;12(1):53. doi: 10.1186/s13643-023-02185-6. Syst Rev. 2023. PMID: 36945033 Free PMC article.

Furthermore, duloxetine significantly improved the patients' quality of life, which was assessed using the Clinical Global Impression severity subscale (MD - 0.48; 95% CI - 0.61 to - 0.36; P < .00001), Patient Global Impression of Improvement scale (MD - 0.50; 95% CI - 0.64 to

…
Furthermore, duloxetine significantly improved the patients' quality of life, which was assessed using the Clinical Global Impression severi …
405 results